Proposed rule of the Medical Board would amend regulations under 21 NCAC 32B and 32M to establish a coronavirus (Covid-19) restricted drug list and standards for physicians or physician assistants and nurse practitioners to prescribe restricted drugs for the treatment of Covid-19. The rule also would remove two drugs from the restricted drug list that is currently in effect under a temporary rule. A hearing is scheduled for Jan. 15, 2021, via teleconference. Comments are due Jan. 15, 2021.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.